EMA Discusses Fatal Events That Prompted Pfizer To Pull Oxbryta From Global Markets

The CHMP is holding an extraordinary meeting to discuss the emerging data for the sickle cell disease drug

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".